A novel esophageal retractor with eccentric balloon during atrial fibrillation ablation
Pacing and Clinical Electrophysiology · 2023
DOI: 10.1111/pace.14794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Wen-Li Dai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Chaoyan…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Due to the anatomically adjacent relationship between the left atrium (LA) and esophagus, energy delivery on the posterior wall of LA is limited. The aim of this study was to evaluate the feasibility of a novel esophageal retractor (SAFER) with an inflatable C‐curve balloon during atrial fibrillation (AF) ablation.
Method
Nine patients underwent AF ablation assisted with the SAFER. After inflation, the esophagus was deviated laterally away from the intended ablation site of the posterior wall under local anesthesia. The extent of mechanical esophageal deviation (MED) was evaluated under fluoroscopy, defined as the shortest distance from the trailing esophageal edge to the closest point of the ablation line. Gastroscopy was performed before and after ablation. The target ablation index used in all LA sites including the posterior wall was 400–450 after effective MED. All adverse events during the periprocedural period were recorded.
Results
The mean deviation distance achieved 16.2 ± 9.6 mm away from the closest ablation point of the pulmonary vein lesion set. With respect to the individual left and right pulmonary vein lesion sets, the deviation distance was 19.7 ± 11.5 and 12.7 ± 6.8 mm, respectively. The extent of deviation was 0 to 5 mm, 5.1 to 10 mm, or >10 mm in 0(0%), 7(38.9%), and 11(61.1%), respectively. Procedural success was achieved in all patients without acute reconnection. There was only one esophageal complication which manifested as esophageal erosion and this patient experienced throat pain possibly related to the SAFER retractor with no clinical sequelae.
Conclusion
Esophageal deviation with the novel eccentric balloon is a novel feasible choice during AF ablation, enabling adequate energy delivery to the posterior wall of LA. Additional prospective randomized controlled studies are required for further validation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Chaoyang-qu, Beijing, China.
ORCID-Profile: Meng-Meng Li, Cai-Hua Sang, Chen-Xi Jiang, Jian-Zeng Dong, Chang-Sheng Ma
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Dai, W. L., Yao, K. X., Li, M. M., Li, S. N., Sang, C. H., Jiang, C. X., Guo, X. Y., Li, X., Feng, L., Jia, C. Q., Ning, M., Dong, J. Z., & Ma, C. S. (2023). A novel esophageal retractor with eccentric balloon during atrial fibrillation ablation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14794
Vancouver
Dai WL, Yao KX, Li MM, Li SN, Sang CH, Jiang CX, et al. A novel esophageal retractor with eccentric balloon during atrial fibrillation ablation. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14794
BibTeX
@article{Dai2023,
author = {Dai, Wen-Li and Yao, Ke-Xin and Li, Meng-Meng and Li, Song-Nan and Sang, Cai-Hua and Jiang, Chen-Xi and Guo, Xue-Yuan and Li, Xu and Feng, Li and Jia, Chang-Qi and Ning, Man and Dong, Jian-Zeng and Ma, Chang-Sheng},
title = {A novel esophageal retractor with eccentric balloon during atrial fibrillation ablation},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
doi = {10.1111/pace.14794}
}
EUVIMED